HLA-C and graft versus host disease: Instead, engrafted human immune cells primarily belong to activated human CD4+ or CD8+ T cell driven by mouse major histocompatibility (MHC) molecules, which cause severe xenogeneic graft vs. host diseases (xeno-GVHD), thereby restricting the experimental window for these animals to few weeks (69).